Decision letter for "Semaglutide and Cardiovascular Risk in Type 1 Diabetes: A Predictive Modeling Analysis in a Double-Blind, Randomized, Placebo-Controlled Cross-Over Trial"
Fields of Study & Subjects
Diabetes Treatment and Management
Diabetes Management and Research
Diabetes
Cardiovascular Risks
and Lipoproteins
Publication details
- Publication date
- 5 January 2026